Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s40425-015-0068-y.

Title:
Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study | Journal for ImmunoTherapy of Cancer
Description:
Background CV9103 is a prostate-cancer vaccine containing self-adjuvanted mRNA (RNActive®) encoding the antigens PSA, PSCA, PSMA, and STEAP1. This phase I/IIa study evaluated safety and immunogenicity of CV9103 in patients with advanced castration-resistant prostate-cancer. Methods 44 Patients received up to 5 intra-dermal vaccinations. Three dose levels of total mRNA were tested in Phase I in cohorts of 3–6 patients to determine a recommended dose. In phase II, 32 additional patients were treated at the recommended dose. The primary endpoint was safety and tolerability, the secondary endpoint was induction of antigen specific immune responses monitored at baseline and at weeks 5, 9 and 17. Results The most frequent adverse events were grade 1/2 injection site erythema, injection site reactions, fatigue, pyrexia, chills and influenza-like illness. Possibly treatment related urinary retention occurred in 3 patients. The recommended dose was 1280 μg. A total of 26/33 evaluable patients treated at 1280 μg developed an immune response, directed against multiple antigens in 15 out of 33 patients. One patient showed a confirmed PSA response. In the subgroup of 36 metastatic patients, the Kaplan-Meier estimate of median overall survival was 31.4 months [95 % CI: 21.2; n.a]. Conclusions The self-adjuvanted RNActive® vaccine CV9103 was well tolerated and immunogenic. The technology is a versatile, fast and cost-effective platform allowing for creation of vaccines. The follow-up vaccine CV9104 including the additional antigens prostatic acid phosphatase (PAP) and Muc1 is currently being tested in a randomized phase IIb trial to assess the clinical benefit induced by this new vaccination approach. Trial registration EU Clinical Trials Register: EudraCT number 2008-003967-37 , registered 27 Jan 2009.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,626,432 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

patients, responses, cancer, immune, pubmed, response, article, cells, prostate, psa, survival, google, scholar, antigen, vaccination, cas, antigens, mrna, dose, phase, cell, study, clinical, analysis, patient, treatment, additional, baseline, vaccines, antigenspecific, week, vaccine, tumor, metastatic, time, table, observed, evaluable, data, trial, cellular, criteria, psca, related, months, germany, file, performed, results, increase,

Topics {✒️}

advanced castration-resistant prostate-cancer göttingen/university hospital mannheim single-agent anti-programmed death-1 dmso-free freezing medium karl-josef kallen cell-mediated antigen-specific immunity poxviral-based psa-targeted immunotherapy castration-resistant prostate cancer johannes-gutenberg-university mainz frank vom dorp enzyme-linked immunosorbent assay trans-membrane spanning protein prostate-specific membrane antigen vaccine-induced antigen-specific cells messenger rna-based vaccines steroidal anti-inflammatory drugs article download pdf cells targeting ny-eso-1 anti-pd1 monoclonal antibody wolfgang schultze-seemann intracellular cytokine staining cmv/eppstein-barr/flu pvdf plates pre-coated anti-ctla-4 monoclonal antibody antigen-specific immunity consisted single-dose cyclophosphamide associates streptavidin-apc-conjugated tetramers anti-ifn-γ antibody supplementary anti-cancer therapy protamine-ringer lactate solution stabilized rna molecules vaccine antigen-specific humoral generation anti-hormonal agents mariola fotin-mleczek cost-effective platform allowing kaplan-meier survival estimates kaplan-meier survival curves bone-scan based progression life-threatening related aes antigen-specific immune responses prostate cancer vaccines pd-1 receptor-deficient mice open access license vaccine-induced immune response direct intra-dermal injection psma dna vaccines ifn-γ-producing cells serum-free media von der kammer peptide-based vaccination approach

Questions {❓}

  • Does the immune system see tumors as foreign or self?
  • Prostate stem cell antigen: a Jekyll and Hyde molecule?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
         description:CV9103 is a prostate-cancer vaccine containing self-adjuvanted mRNA (RNActive®) encoding the antigens PSA, PSCA, PSMA, and STEAP1. This phase I/IIa study evaluated safety and immunogenicity of CV9103 in patients with advanced castration-resistant prostate-cancer. 44 Patients received up to 5 intra-dermal vaccinations. Three dose levels of total mRNA were tested in Phase I in cohorts of 3–6 patients to determine a recommended dose. In phase II, 32 additional patients were treated at the recommended dose. The primary endpoint was safety and tolerability, the secondary endpoint was induction of antigen specific immune responses monitored at baseline and at weeks 5, 9 and 17. The most frequent adverse events were grade 1/2 injection site erythema, injection site reactions, fatigue, pyrexia, chills and influenza-like illness. Possibly treatment related urinary retention occurred in 3 patients. The recommended dose was 1280 μg. A total of 26/33 evaluable patients treated at 1280 μg developed an immune response, directed against multiple antigens in 15 out of 33 patients. One patient showed a confirmed PSA response. In the subgroup of 36 metastatic patients, the Kaplan-Meier estimate of median overall survival was 31.4 months [95 % CI: 21.2; n.a]. The self-adjuvanted RNActive® vaccine CV9103 was well tolerated and immunogenic. The technology is a versatile, fast and cost-effective platform allowing for creation of vaccines. The follow-up vaccine CV9104 including the additional antigens prostatic acid phosphatase (PAP) and Muc1 is currently being tested in a randomized phase IIb trial to assess the clinical benefit induced by this new vaccination approach. EU Clinical Trials Register: EudraCT number 2008-003967-37 , registered 27 Jan 2009.
         datePublished:2015-06-16T00:00:00Z
         dateModified:2015-06-16T00:00:00Z
         pageStart:1
         pageEnd:14
         license:https://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s40425-015-0068-y
         keywords:
            Enzalutamide
            Cabazitaxel
            Intracellular Cytokine Staining
            Prostate Stem Cell Antigen
            Tetramer Staining
            Oncology
            Immunology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-015-0068-y/MediaObjects/40425_2015_68_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-015-0068-y/MediaObjects/40425_2015_68_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-015-0068-y/MediaObjects/40425_2015_68_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-015-0068-y/MediaObjects/40425_2015_68_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-015-0068-y/MediaObjects/40425_2015_68_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-015-0068-y/MediaObjects/40425_2015_68_Fig6_HTML.gif
         isPartOf:
            name:Journal for Immunotherapy of Cancer
            issn:
               2051-1426
            volumeNumber:3
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Hubert Kübler
               affiliation:
                     name:Klinikum rechts der Isar der Technischen Universität München
                     address:
                        name:Klinikum rechts der Isar der Technischen Universität München, Munich, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Birgit Scheel
               affiliation:
                     name:CureVac GmbH
                     address:
                        name:CureVac GmbH, Tuebingen, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Ulrike Gnad-Vogt
               affiliation:
                     name:CureVac GmbH
                     address:
                        name:CureVac GmbH, Tuebingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kurt Miller
               affiliation:
                     name:Charité University Hospital Berlin
                     address:
                        name:Charité University Hospital Berlin, Berlin, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wolfgang Schultze-Seemann
               affiliation:
                     name:University Hospital Freiburg
                     address:
                        name:University Hospital Freiburg, Freiburg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Frank vom Dorp
               affiliation:
                     name:Universitäty Hospital Essen
                     address:
                        name:Universitäty Hospital Essen, Essen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Giorgio Parmiani
               affiliation:
                     name:San Raffaele Scientific Institute
                     address:
                        name:San Raffaele Scientific Institute, Milan, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Christian Hampel
               affiliation:
                     name:University Hospital of the Johannes-Gutenberg-University Mainz
                     address:
                        name:University Hospital of the Johannes-Gutenberg-University Mainz, Mainz, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Steffen Wedel
               affiliation:
                     name:Ortenau Klinikum Offenburg-Gengenbach
                     address:
                        name:Ortenau Klinikum Offenburg-Gengenbach, Offenburg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lutz Trojan
               affiliation:
                     name:University Hospital Göttingen, Göttingen/University Hospital Mannheim
                     address:
                        name:University Hospital Göttingen, Göttingen/University Hospital Mannheim, Mannheim, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Dieter Jocham
               affiliation:
                     name:University Hospital Schleswig-Holstein Campus Luebeck
                     address:
                        name:University Hospital Schleswig-Holstein Campus Luebeck, Luebeck, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tobias Maurer
               affiliation:
                     name:Klinikum rechts der Isar der Technischen Universität München
                     address:
                        name:Klinikum rechts der Isar der Technischen Universität München, Munich, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gerd Rippin
               affiliation:
                     name:Rippin-Consulting
                     address:
                        name:Rippin-Consulting, Solingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mariola Fotin-Mleczek
               affiliation:
                     name:CureVac GmbH
                     address:
                        name:CureVac GmbH, Tuebingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Florian von der Mülbe
               affiliation:
                     name:CureVac GmbH
                     address:
                        name:CureVac GmbH, Tuebingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jochen Probst
               affiliation:
                     name:CureVac GmbH
                     address:
                        name:CureVac GmbH, Tuebingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ingmar Hoerr
               affiliation:
                     name:CureVac GmbH
                     address:
                        name:CureVac GmbH, Tuebingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Karl-Josef Kallen
               affiliation:
                     name:CureVac GmbH
                     address:
                        name:CureVac GmbH, Tuebingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Thomas Lander
               affiliation:
                     name:CureVac GmbH
                     address:
                        name:CureVac GmbH, Tuebingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Arnulf Stenzl
               affiliation:
                     name:University Hospital Tuebingen
                     address:
                        name:University Hospital Tuebingen, Tuebingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
      description:CV9103 is a prostate-cancer vaccine containing self-adjuvanted mRNA (RNActive®) encoding the antigens PSA, PSCA, PSMA, and STEAP1. This phase I/IIa study evaluated safety and immunogenicity of CV9103 in patients with advanced castration-resistant prostate-cancer. 44 Patients received up to 5 intra-dermal vaccinations. Three dose levels of total mRNA were tested in Phase I in cohorts of 3–6 patients to determine a recommended dose. In phase II, 32 additional patients were treated at the recommended dose. The primary endpoint was safety and tolerability, the secondary endpoint was induction of antigen specific immune responses monitored at baseline and at weeks 5, 9 and 17. The most frequent adverse events were grade 1/2 injection site erythema, injection site reactions, fatigue, pyrexia, chills and influenza-like illness. Possibly treatment related urinary retention occurred in 3 patients. The recommended dose was 1280 μg. A total of 26/33 evaluable patients treated at 1280 μg developed an immune response, directed against multiple antigens in 15 out of 33 patients. One patient showed a confirmed PSA response. In the subgroup of 36 metastatic patients, the Kaplan-Meier estimate of median overall survival was 31.4 months [95 % CI: 21.2; n.a]. The self-adjuvanted RNActive® vaccine CV9103 was well tolerated and immunogenic. The technology is a versatile, fast and cost-effective platform allowing for creation of vaccines. The follow-up vaccine CV9104 including the additional antigens prostatic acid phosphatase (PAP) and Muc1 is currently being tested in a randomized phase IIb trial to assess the clinical benefit induced by this new vaccination approach. EU Clinical Trials Register: EudraCT number 2008-003967-37 , registered 27 Jan 2009.
      datePublished:2015-06-16T00:00:00Z
      dateModified:2015-06-16T00:00:00Z
      pageStart:1
      pageEnd:14
      license:https://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s40425-015-0068-y
      keywords:
         Enzalutamide
         Cabazitaxel
         Intracellular Cytokine Staining
         Prostate Stem Cell Antigen
         Tetramer Staining
         Oncology
         Immunology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-015-0068-y/MediaObjects/40425_2015_68_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-015-0068-y/MediaObjects/40425_2015_68_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-015-0068-y/MediaObjects/40425_2015_68_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-015-0068-y/MediaObjects/40425_2015_68_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-015-0068-y/MediaObjects/40425_2015_68_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-015-0068-y/MediaObjects/40425_2015_68_Fig6_HTML.gif
      isPartOf:
         name:Journal for Immunotherapy of Cancer
         issn:
            2051-1426
         volumeNumber:3
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Hubert Kübler
            affiliation:
                  name:Klinikum rechts der Isar der Technischen Universität München
                  address:
                     name:Klinikum rechts der Isar der Technischen Universität München, Munich, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Birgit Scheel
            affiliation:
                  name:CureVac GmbH
                  address:
                     name:CureVac GmbH, Tuebingen, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Ulrike Gnad-Vogt
            affiliation:
                  name:CureVac GmbH
                  address:
                     name:CureVac GmbH, Tuebingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kurt Miller
            affiliation:
                  name:Charité University Hospital Berlin
                  address:
                     name:Charité University Hospital Berlin, Berlin, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wolfgang Schultze-Seemann
            affiliation:
                  name:University Hospital Freiburg
                  address:
                     name:University Hospital Freiburg, Freiburg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Frank vom Dorp
            affiliation:
                  name:Universitäty Hospital Essen
                  address:
                     name:Universitäty Hospital Essen, Essen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Giorgio Parmiani
            affiliation:
                  name:San Raffaele Scientific Institute
                  address:
                     name:San Raffaele Scientific Institute, Milan, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Christian Hampel
            affiliation:
                  name:University Hospital of the Johannes-Gutenberg-University Mainz
                  address:
                     name:University Hospital of the Johannes-Gutenberg-University Mainz, Mainz, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Steffen Wedel
            affiliation:
                  name:Ortenau Klinikum Offenburg-Gengenbach
                  address:
                     name:Ortenau Klinikum Offenburg-Gengenbach, Offenburg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lutz Trojan
            affiliation:
                  name:University Hospital Göttingen, Göttingen/University Hospital Mannheim
                  address:
                     name:University Hospital Göttingen, Göttingen/University Hospital Mannheim, Mannheim, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Dieter Jocham
            affiliation:
                  name:University Hospital Schleswig-Holstein Campus Luebeck
                  address:
                     name:University Hospital Schleswig-Holstein Campus Luebeck, Luebeck, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tobias Maurer
            affiliation:
                  name:Klinikum rechts der Isar der Technischen Universität München
                  address:
                     name:Klinikum rechts der Isar der Technischen Universität München, Munich, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gerd Rippin
            affiliation:
                  name:Rippin-Consulting
                  address:
                     name:Rippin-Consulting, Solingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mariola Fotin-Mleczek
            affiliation:
                  name:CureVac GmbH
                  address:
                     name:CureVac GmbH, Tuebingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Florian von der Mülbe
            affiliation:
                  name:CureVac GmbH
                  address:
                     name:CureVac GmbH, Tuebingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jochen Probst
            affiliation:
                  name:CureVac GmbH
                  address:
                     name:CureVac GmbH, Tuebingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ingmar Hoerr
            affiliation:
                  name:CureVac GmbH
                  address:
                     name:CureVac GmbH, Tuebingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Karl-Josef Kallen
            affiliation:
                  name:CureVac GmbH
                  address:
                     name:CureVac GmbH, Tuebingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Thomas Lander
            affiliation:
                  name:CureVac GmbH
                  address:
                     name:CureVac GmbH, Tuebingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Arnulf Stenzl
            affiliation:
                  name:University Hospital Tuebingen
                  address:
                     name:University Hospital Tuebingen, Tuebingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal for Immunotherapy of Cancer
      issn:
         2051-1426
      volumeNumber:3
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Klinikum rechts der Isar der Technischen Universität München
      address:
         name:Klinikum rechts der Isar der Technischen Universität München, Munich, Germany
         type:PostalAddress
      name:CureVac GmbH
      address:
         name:CureVac GmbH, Tuebingen, Germany
         type:PostalAddress
      name:CureVac GmbH
      address:
         name:CureVac GmbH, Tuebingen, Germany
         type:PostalAddress
      name:Charité University Hospital Berlin
      address:
         name:Charité University Hospital Berlin, Berlin, Germany
         type:PostalAddress
      name:University Hospital Freiburg
      address:
         name:University Hospital Freiburg, Freiburg, Germany
         type:PostalAddress
      name:Universitäty Hospital Essen
      address:
         name:Universitäty Hospital Essen, Essen, Germany
         type:PostalAddress
      name:San Raffaele Scientific Institute
      address:
         name:San Raffaele Scientific Institute, Milan, Italy
         type:PostalAddress
      name:University Hospital of the Johannes-Gutenberg-University Mainz
      address:
         name:University Hospital of the Johannes-Gutenberg-University Mainz, Mainz, Germany
         type:PostalAddress
      name:Ortenau Klinikum Offenburg-Gengenbach
      address:
         name:Ortenau Klinikum Offenburg-Gengenbach, Offenburg, Germany
         type:PostalAddress
      name:University Hospital Göttingen, Göttingen/University Hospital Mannheim
      address:
         name:University Hospital Göttingen, Göttingen/University Hospital Mannheim, Mannheim, Germany
         type:PostalAddress
      name:University Hospital Schleswig-Holstein Campus Luebeck
      address:
         name:University Hospital Schleswig-Holstein Campus Luebeck, Luebeck, Germany
         type:PostalAddress
      name:Klinikum rechts der Isar der Technischen Universität München
      address:
         name:Klinikum rechts der Isar der Technischen Universität München, Munich, Germany
         type:PostalAddress
      name:Rippin-Consulting
      address:
         name:Rippin-Consulting, Solingen, Germany
         type:PostalAddress
      name:CureVac GmbH
      address:
         name:CureVac GmbH, Tuebingen, Germany
         type:PostalAddress
      name:CureVac GmbH
      address:
         name:CureVac GmbH, Tuebingen, Germany
         type:PostalAddress
      name:CureVac GmbH
      address:
         name:CureVac GmbH, Tuebingen, Germany
         type:PostalAddress
      name:CureVac GmbH
      address:
         name:CureVac GmbH, Tuebingen, Germany
         type:PostalAddress
      name:CureVac GmbH
      address:
         name:CureVac GmbH, Tuebingen, Germany
         type:PostalAddress
      name:CureVac GmbH
      address:
         name:CureVac GmbH, Tuebingen, Germany
         type:PostalAddress
      name:University Hospital Tuebingen
      address:
         name:University Hospital Tuebingen, Tuebingen, Germany
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Hubert Kübler
      affiliation:
            name:Klinikum rechts der Isar der Technischen Universität München
            address:
               name:Klinikum rechts der Isar der Technischen Universität München, Munich, Germany
               type:PostalAddress
            type:Organization
      name:Birgit Scheel
      affiliation:
            name:CureVac GmbH
            address:
               name:CureVac GmbH, Tuebingen, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Ulrike Gnad-Vogt
      affiliation:
            name:CureVac GmbH
            address:
               name:CureVac GmbH, Tuebingen, Germany
               type:PostalAddress
            type:Organization
      name:Kurt Miller
      affiliation:
            name:Charité University Hospital Berlin
            address:
               name:Charité University Hospital Berlin, Berlin, Germany
               type:PostalAddress
            type:Organization
      name:Wolfgang Schultze-Seemann
      affiliation:
            name:University Hospital Freiburg
            address:
               name:University Hospital Freiburg, Freiburg, Germany
               type:PostalAddress
            type:Organization
      name:Frank vom Dorp
      affiliation:
            name:Universitäty Hospital Essen
            address:
               name:Universitäty Hospital Essen, Essen, Germany
               type:PostalAddress
            type:Organization
      name:Giorgio Parmiani
      affiliation:
            name:San Raffaele Scientific Institute
            address:
               name:San Raffaele Scientific Institute, Milan, Italy
               type:PostalAddress
            type:Organization
      name:Christian Hampel
      affiliation:
            name:University Hospital of the Johannes-Gutenberg-University Mainz
            address:
               name:University Hospital of the Johannes-Gutenberg-University Mainz, Mainz, Germany
               type:PostalAddress
            type:Organization
      name:Steffen Wedel
      affiliation:
            name:Ortenau Klinikum Offenburg-Gengenbach
            address:
               name:Ortenau Klinikum Offenburg-Gengenbach, Offenburg, Germany
               type:PostalAddress
            type:Organization
      name:Lutz Trojan
      affiliation:
            name:University Hospital Göttingen, Göttingen/University Hospital Mannheim
            address:
               name:University Hospital Göttingen, Göttingen/University Hospital Mannheim, Mannheim, Germany
               type:PostalAddress
            type:Organization
      name:Dieter Jocham
      affiliation:
            name:University Hospital Schleswig-Holstein Campus Luebeck
            address:
               name:University Hospital Schleswig-Holstein Campus Luebeck, Luebeck, Germany
               type:PostalAddress
            type:Organization
      name:Tobias Maurer
      affiliation:
            name:Klinikum rechts der Isar der Technischen Universität München
            address:
               name:Klinikum rechts der Isar der Technischen Universität München, Munich, Germany
               type:PostalAddress
            type:Organization
      name:Gerd Rippin
      affiliation:
            name:Rippin-Consulting
            address:
               name:Rippin-Consulting, Solingen, Germany
               type:PostalAddress
            type:Organization
      name:Mariola Fotin-Mleczek
      affiliation:
            name:CureVac GmbH
            address:
               name:CureVac GmbH, Tuebingen, Germany
               type:PostalAddress
            type:Organization
      name:Florian von der Mülbe
      affiliation:
            name:CureVac GmbH
            address:
               name:CureVac GmbH, Tuebingen, Germany
               type:PostalAddress
            type:Organization
      name:Jochen Probst
      affiliation:
            name:CureVac GmbH
            address:
               name:CureVac GmbH, Tuebingen, Germany
               type:PostalAddress
            type:Organization
      name:Ingmar Hoerr
      affiliation:
            name:CureVac GmbH
            address:
               name:CureVac GmbH, Tuebingen, Germany
               type:PostalAddress
            type:Organization
      name:Karl-Josef Kallen
      affiliation:
            name:CureVac GmbH
            address:
               name:CureVac GmbH, Tuebingen, Germany
               type:PostalAddress
            type:Organization
      name:Thomas Lander
      affiliation:
            name:CureVac GmbH
            address:
               name:CureVac GmbH, Tuebingen, Germany
               type:PostalAddress
            type:Organization
      name:Arnulf Stenzl
      affiliation:
            name:University Hospital Tuebingen
            address:
               name:University Hospital Tuebingen, Tuebingen, Germany
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Klinikum rechts der Isar der Technischen Universität München, Munich, Germany
      name:CureVac GmbH, Tuebingen, Germany
      name:CureVac GmbH, Tuebingen, Germany
      name:Charité University Hospital Berlin, Berlin, Germany
      name:University Hospital Freiburg, Freiburg, Germany
      name:Universitäty Hospital Essen, Essen, Germany
      name:San Raffaele Scientific Institute, Milan, Italy
      name:University Hospital of the Johannes-Gutenberg-University Mainz, Mainz, Germany
      name:Ortenau Klinikum Offenburg-Gengenbach, Offenburg, Germany
      name:University Hospital Göttingen, Göttingen/University Hospital Mannheim, Mannheim, Germany
      name:University Hospital Schleswig-Holstein Campus Luebeck, Luebeck, Germany
      name:Klinikum rechts der Isar der Technischen Universität München, Munich, Germany
      name:Rippin-Consulting, Solingen, Germany
      name:CureVac GmbH, Tuebingen, Germany
      name:CureVac GmbH, Tuebingen, Germany
      name:CureVac GmbH, Tuebingen, Germany
      name:CureVac GmbH, Tuebingen, Germany
      name:CureVac GmbH, Tuebingen, Germany
      name:CureVac GmbH, Tuebingen, Germany
      name:University Hospital Tuebingen, Tuebingen, Germany

External Links {🔗}(217)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.82s.